June 2022, Vol 308, No 7962
Opioids: what can be done about long-term prescribing?
Top news stories
More than a quarter of patients overusing rescue inhalers for asthma, study finds
No new funding for supervisors to support 3,000 pharmacist independent prescribing trainees
Features
In figures: the rise in long-term opioid use
Opioids: what can be done about long-term prescribing?
Long COVID: the NHS staff forced back to work too soon
More than a quarter of patients overusing rescue inhalers for asthma, study finds
Shifting the scales: a promising new era for weight-loss drugs
Opinion
PJ view: Pharmacists must be allowed more time for structured medication reviews
Using genetic testing to prevent DPD toxicity
SARS-CoV2 antivirals are essential, but they are not silver bullets
How pharmacists can be integral to patient care on a ‘virtual ward’
From locum to pharmacy owner before turning 30
Pharmacies and opioid dependency: working together to better support recovery
Pharmacy services for shielding patients should act as a blueprint for those who are housebound
Learning & CPD
Renal cancer: management
Supported content
Glucagon-like peptide-1 analogues in adults with type 2 diabetes mellitus for glycaemic control
Familial hypercholesterolaemia: identification and management
DPYD genetic testing and the future of pharmacogenomic testing in routine care
Management of Parkinson’s disease
Your RPS
RPS publishes first-ever blueprint for advanced pharmacist core practice
Pharmacies able to apply for environmentally sustainable awards
RPS vision for pharmacy by 2030 will ‘enhance patient care’, says MSP
RPS publishes guidance on expanding scope of prescribing
